|
Naureen Quibria, Ph.D.
|
Bio
Naureen Quibria, Ph.D. joined Noble Capital Markets as a Senior Research Analyst in December 2020. Prior to joining the firm, she was a Senior Biotechnology Analyst at Maxim Group. She began her career in equity research at H.C. Wainwright, followed by JMP Securities. She has also served in various consulting roles, including as Business Analyst at Johns Hopkins Technology Ventures. She has conducted research in academic labs at the NIH, Beth Israel Deaconess Medical Center/Harvard Medical School and UCLA. Dr. Quibria received her Ph.D. in Cell Biology and Pathology from Columbia University and holds a Bachelor’s degree in Biology from Bryn Mawr College.
Credentials
Senior Equity Research Analyst focusing on the Life Sciences sector. 5 years of industry experience. PhD in Cell Biology and Pathology from Columbia University. Bachelor’s degree in Biology from Bryn Mawr College. Post-Doctoral training at Columbia University and New York University. Conducted research in academic labs at the NIH, Beth Israel Deaconess Medical Center/Harvard Medical School and UCLA.
FINRA licenses 7, 63, 86, 87.
Coverage List